Choriocarcinoma
A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).
Subtype terms (2)
More specific conditions that are subtypes of Choriocarcinoma in the MeSH hierarchy.
- Choriocarcinoma, Non-gestational
- Trophoblastic Tumor, Placental Site
2 drugs (1 approved, 1 experimental)
Drugs by status
Approved for this indication (3)
Phase 3 trials (10)
Phase 2 trials (7)
Organizations
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (2)